speb/financial-data huggingface dataset:
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 22663000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 83642000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 313867000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 135759963.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 0.01
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 135760000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 10780000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 174390000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 135760000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1617786000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 65957000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 302876000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 9876000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 9876000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 150726000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 928000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 16892000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 16892000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 135759963.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.01
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 7585000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — EBIT: 5856000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — EBITDA: 22748000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 27710000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 1560000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 1560000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1683306000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 313867000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 55644000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 55644000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 134896000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Minority Interests: 5916000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 54740000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Net Income: 7585000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 7585000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 1669000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 7585000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 7585000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 1669000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -1560000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -1560000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 448738000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 1617786000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: -18856000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 22748000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 7585000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Operating Income: -14397000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 93667000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 135759963.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 44844000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 117259000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 1482026000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 1000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 1000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 18285000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 17810000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 163610000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Payables: 22663000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 4296000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 65957000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 16892000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 135759963.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1617786000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 1617786000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 2627000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.30
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 1968710000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1673430000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 65520000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1752682000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 108064000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 216028000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1665834000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 65302000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 152150000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 53882000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 234204000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 149166667.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 0.27
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 199318000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 18853000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 18853000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 149166667.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.27
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 40275000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — EBIT: 49882000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — EBITDA: 68735000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 34886000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 4282000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 4282000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 3272000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Net Income: 40275000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 40275000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 37003000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 40275000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 40275000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 37003000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -4282000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -4282000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 68735000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 40275000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Operating Income: -18996000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 234204000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 68084000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 26040000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 45600000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 199318000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 18853000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 8597000.00
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.19
SURANAT&P.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 253200000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — +Operating Expense: 241042000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 101164000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — +Total Revenue: 607949000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 238642000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 130000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 130000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 430236000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 430236000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 296677000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 296677000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 156012579.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 153469027.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Basic EPS: 1.59
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 1.13
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 31322000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -890617000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 135760000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 135760000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 6107000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 6107000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 30369000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 30369000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Change In Inventory: 0.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: 45251000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Change In Payable: 80028000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -400480000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -275201000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -25216000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Common Stock: 135760000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 135760000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 1819797000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1819797000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 462402000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 197127000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Current Assets: 496895000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 496895000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Current Debt: 135732000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 135732000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 135732000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 135732000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 218218000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 218218000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 829000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 829000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Depreciation: 70054000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 70054000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 68093000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 14475000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 68093000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 14475000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 156012579.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 153469027.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Diluted EPS: 1.59
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.13
SURANAT&P.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 248060000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 173420000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — EBIT: 291555000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — EBIT: 204511000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — EBITDA: 361609000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — EBITDA: 218986000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — End Cash Position: 6107000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 581452000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -1179340000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -312579000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Gross Profit: 145547000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 41515000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Interest Expense: 22418000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 15226000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 22418000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 15226000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -22418000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 69511000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 2484883000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 2484883000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -317945000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 296677000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 296677000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 529354000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 529354000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 529354000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 529354000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 111451000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 111451000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Minority Interests: 31655000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Minority Interests: 20174000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Net Debt: 658979000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 658979000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Net Income: 248060000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Net Income: 173420000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 248060000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 173420000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 216406000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 153247000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 248060000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 173420000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 248060000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 173420000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 264634000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 216408000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 153247000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Net Interest Income: -22418000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -15226000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 251685000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 600802000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 600802000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -22418000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -15226000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: 3068000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: 1000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Net PPE: 1240198000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 1240198000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -649099000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 1819797000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 1819797000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 18643000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 18643000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 127543000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -15080000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Normalized Income: 59853670.90
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Normalized Income: -16082138.58
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: -288723000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Operating Income: -95495000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Operating Income: -59649000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Operating Revenue: 607949000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 238642000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 135759963.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 135759963.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 36290000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 36290000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 69780000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 69780000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 1684037000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 1684037000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 10675000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 1000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 148480000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 29361000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 142030000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 79422000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 24262000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 24262000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Other Special Charges: -234066000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Other Special Charges: -234066000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Payables: 6813000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Payables: 6813000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Pretax Income: 269137000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 189285000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -3026000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -890617000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 462402000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 197127000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 70054000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 14475000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 254711000.00
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 241518000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Share Issued: 135759963.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 135759963.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Special Income Charges: 234066000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 234066000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 1819797000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1819797000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 1819797000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 1819797000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 45859670.90
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 44563861.42
SURANAT&P.NS income_statement (annual, 2026-03-31) — Tax Provision: 52731000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 36038000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.20
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.19
SURANAT&P.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -46360000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Total Assets: 2710009000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 2710009000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 2349151000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 2349151000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Total Debt: 665086000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 665086000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 1931248000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1931248000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Total Expenses: 703444000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 298291000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 778761000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 778761000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 2213113000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 2213113000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 560543000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 560543000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 6683000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 6683000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 234066000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 234066000.00
SURANAT&P.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 234066000.00
SURANAT&P.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 234066000.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Treasury Shares Number: 0.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 0.00
SURANAT&P.NS balance_sheet (annual, 2026-03-31) — Working Capital: 278677000.00
SURANAT&P.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 278677000.00
SURE.L income_statement (annual, 2022-03-31) — +Operating Expense: 291821.00
SURE.L income_statement (annual, 2022-03-31) — +Total Revenue: 2488278.00
SURE.L balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 5768780.00
SURE.L income_statement (annual, 2022-03-31) — Basic Average Shares: 5878910.00
SURE.L income_statement (annual, 2022-03-31) — Basic EPS: 0.37
SURE.L cash_flow (annual, 2022-03-31) — Beginning Cash Position: 1255199.00
SURE.L balance_sheet (annual, 2022-03-31) — Capital Stock: 60132.00
SURE.L balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 282178.00
SURE.L balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Federal Funds Sold: 282178.00
SURE.L cash_flow (annual, 2022-03-31) — Change In Other Current Liabilities: 0.00
SURE.L cash_flow (annual, 2022-03-31) — Change In Payable: -5197.00
SURE.L cash_flow (annual, 2022-03-31) — Change In Receivables: -1600.00
SURE.L cash_flow (annual, 2022-03-31) — Change In Working Capital: -6797.00
SURE.L cash_flow (annual, 2022-03-31) — Changes In Cash: -973021.00
SURE.L balance_sheet (annual, 2022-03-31) — Common Stock: 60132.00
SURE.L balance_sheet (annual, 2022-03-31) — Common Stock Equity: 7751596.00
SURE.L cash_flow (annual, 2022-03-31) — Common Stock Issuance: 662500.00
SURE.L income_statement (annual, 2022-03-31) — Diluted Average Shares: 5878910.00
SURE.L income_statement (annual, 2022-03-31) — Diluted EPS: 0.37
SURE.L income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 2196457.00
SURE.L cash_flow (annual, 2022-03-31) — End Cash Position: 282178.00
SURE.L balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 7516667.00
SURE.L cash_flow (annual, 2022-03-31) — Financing Cash Flow: 629375.00
SURE.L cash_flow (annual, 2022-03-31) — Free Cash Flow: -298618.00
SURE.L cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: -2538562.00
SURE.L income_statement (annual, 2022-03-31) — Gain On Sale Of Security: 128800.00
SURE.L income_statement (annual, 2022-03-31) — General And Administrative Expense: 260978.00
SURE.L income_statement (annual, 2022-03-31) — Interest Expense: 0.00
SURE.L income_statement (annual, 2022-03-31) — Interest Income: 0.00
SURE.L cash_flow (annual, 2022-03-31) — Investing Cash Flow: -1303778.00
SURE.L balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 7516667.00
SURE.L balance_sheet (annual, 2022-03-31) — Investments And Advances: 7516667.00
SURE.L cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 662500.00
SURE.L cash_flow (annual, 2022-03-31) — Issuance Of Debt: 0.00
SURE.L cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 0.00
SURE.L cash_flow (annual, 2022-03-31) — Long Term Debt Payments: 0.00
SURE.L cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 662500.00
SURE.L cash_flow (annual, 2022-03-31) — Net Foreign Currency Exchange Gain Loss: 50284.00
SURE.L income_statement (annual, 2022-03-31) — Net Income: 2196457.00
SURE.L income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 2196457.00
SURE.L income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 2196457.00
SURE.L income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 2196457.00
SURE.L income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 2196457.00
SURE.L cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: 2196457.00
SURE.L income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 2196457.00
SURE.L income_statement (annual, 2022-03-31) — Net Interest Income: 0.00
SURE.L cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: -1303778.00
SURE.L cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: 0.00
SURE.L cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: 0.00
SURE.L cash_flow (annual, 2022-03-31) — Net Other Financing Charges: 0.00
SURE.L balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 7751596.00
SURE.L income_statement (annual, 2022-03-31) — Normalized Income: 2196457.00
SURE.L cash_flow (annual, 2022-03-31) — Operating Cash Flow: -298618.00
SURE.L income_statement (annual, 2022-03-31) — Operating Revenue: 2488278.00
SURE.L balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 6013225.00
SURE.L income_statement (annual, 2022-03-31) — Other Operating Expenses: 30843.00
SURE.L balance_sheet (annual, 2022-03-31) — Prepaid Assets: 1600.00
SURE.L income_statement (annual, 2022-03-31) — Pretax Income: 2196457.00
SURE.L cash_flow (annual, 2022-03-31) — Purchase Of Investment: -1693939.00
SURE.L cash_flow (annual, 2022-03-31) — Repayment Of Debt: 0.00
SURE.L cash_flow (annual, 2022-03-31) — Sale Of Investment: 390161.00
SURE.L income_statement (annual, 2022-03-31) — Selling General And Administration: 260978.00
SURE.L balance_sheet (annual, 2022-03-31) — Share Issued: 6013225.00
SURE.L balance_sheet (annual, 2022-03-31) — Stockholders Equity: 7751596.00
SURE.L balance_sheet (annual, 2022-03-31) — Tangible Book Value: 7751596.00
SURE.L income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 0.00
SURE.L income_statement (annual, 2022-03-31) — Tax Provision: 0.00
SURE.L income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.00
SURE.L balance_sheet (annual, 2022-03-31) — Total Assets: 7800445.00
SURE.L balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 7751596.00
SURE.L balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 48849.00
SURE.L income_statement (annual, 2023-03-31) — +Operating Expense: 272232.00
SURE.L income_statement (annual, 2023-03-31) — +Total Revenue: -157406.00
SURE.L balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 6403697.00
SURE.L income_statement (annual, 2023-03-31) — Basic Average Shares: 6413341.00
SURE.L income_statement (annual, 2023-03-31) — Basic EPS: -0.07
SURE.L cash_flow (annual, 2023-03-31) — Beginning Cash Position: 282178.00
SURE.L balance_sheet (annual, 2023-03-31) — Capital Stock: 66464.00
SURE.L balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 36697.00
SURE.L balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Federal Funds Sold: 36697.00
SURE.L cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 0.00
SURE.L cash_flow (annual, 2023-03-31) — Change In Payable: 23034.00
SURE.L cash_flow (annual, 2023-03-31) — Change In Receivables: -640.00
SURE.L cash_flow (annual, 2023-03-31) — Change In Working Capital: 22394.00
SURE.L cash_flow (annual, 2023-03-31) — Changes In Cash: -245481.00
SURE.L balance_sheet (annual, 2023-03-31) — Common Stock: 66464.00
SURE.L balance_sheet (annual, 2023-03-31) — Common Stock Equity: 7963207.00
SURE.L cash_flow (annual, 2023-03-31) — Common Stock Issuance: 674999.00
SURE.L income_statement (annual, 2023-03-31) — Diluted Average Shares: 6413341.00
SURE.L income_statement (annual, 2023-03-31) — Diluted EPS: -0.07
SURE.L income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -429638.00
SURE.L cash_flow (annual, 2023-03-31) — End Cash Position: 36697.00
SURE.L balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 8196153.00
SURE.L cash_flow (annual, 2023-03-31) — Financing Cash Flow: 841249.00
SURE.L cash_flow (annual, 2023-03-31) — Free Cash Flow: -306996.00
SURE.L cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: 304393.00
SURE.L income_statement (annual, 2023-03-31) — Gain On Sale Of Security: 0.00
SURE.L income_statement (annual, 2023-03-31) — General And Administrative Expense: 236708.00
SURE.L income_statement (annual, 2023-03-31) — Interest Expense: 7158.00
SURE.L income_statement (annual, 2023-03-31) — Interest Income: 0.00
SURE.L balance_sheet (annual, 2023-03-31) — Invested Capital: 8163207.00
SURE.L cash_flow (annual, 2023-03-31) — Investing Cash Flow: -779734.00
SURE.L balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 8196153.00
SURE.L balance_sheet (annual, 2023-03-31) — Investments And Advances: 8196153.00
SURE.L cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 674999.00
SURE.L cash_flow (annual, 2023-03-31) — Issuance Of Debt: 400000.00
SURE.L balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 200000.00
SURE.L cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 400000.00
SURE.L cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -200000.00
SURE.L cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 674999.00
SURE.L balance_sheet (annual, 2023-03-31) — Net Debt: 163303.00
SURE.L cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -204145.00
SURE.L income_statement (annual, 2023-03-31) — Net Income: -429638.00
SURE.L income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -429638.00
SURE.L income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -429638.00
SURE.L income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -429638.00
SURE.L income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -429638.00
SURE.L cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: -429638.00
SURE.L income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -429638.00
SURE.L income_statement (annual, 2023-03-31) — Net Interest Income: -7158.00
SURE.L cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -779734.00
SURE.L cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 200000.00
SURE.L cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 200000.00
SURE.L cash_flow (annual, 2023-03-31) — Net Other Financing Charges: 0.00
SURE.L balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 7963207.00
SURE.L income_statement (annual, 2023-03-31) — Normalized Income: -429638.00
SURE.L cash_flow (annual, 2023-03-31) — Operating Cash Flow: -306996.00
SURE.L income_statement (annual, 2023-03-31) — Operating Revenue: -157406.00
SURE.L balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 6646472.00
SURE.L income_statement (annual, 2023-03-31) — Other Operating Expenses: 35524.00
SURE.L balance_sheet (annual, 2023-03-31) — Other Payable: 7145.00
SURE.L balance_sheet (annual, 2023-03-31) — Payables: 7145.00
SURE.L balance_sheet (annual, 2023-03-31) — Prepaid Assets: 2240.00
SURE.L income_statement (annual, 2023-03-31) — Pretax Income: -429638.00
SURE.L cash_flow (annual, 2023-03-31) — Purchase Of Investment: -779734.00
SURE.L cash_flow (annual, 2023-03-31) — Repayment Of Debt: -200000.00
SURE.L cash_flow (annual, 2023-03-31) — Sale Of Investment: 0.00
SURE.L income_statement (annual, 2023-03-31) — Selling General And Administration: 236708.00
SURE.L balance_sheet (annual, 2023-03-31) — Share Issued: 6646472.00
SURE.L balance_sheet (annual, 2023-03-31) — Stockholders Equity: 7963207.00
SURE.L balance_sheet (annual, 2023-03-31) — Tangible Book Value: 7963207.00
SURE.L income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
SURE.L income_statement (annual, 2023-03-31) — Tax Provision: 0.00
SURE.L income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.00
SURE.L balance_sheet (annual, 2023-03-31) — Total Assets: 8235090.00
SURE.L balance_sheet (annual, 2023-03-31) — Total Capitalization: 8163207.00
SURE.L balance_sheet (annual, 2023-03-31) — Total Debt: 200000.00
SURE.L balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 7963207.00
SURE.L balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 271883.00
SURE.L balance_sheet (annual, 2023-03-31) — Treasury Shares Number: 0.00
SURE.L income_statement (annual, 2024-03-31) — +Operating Expense: 295940.00
SURE.L income_statement (annual, 2024-03-31) — +Total Revenue: -2230538.00
SURE.L balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 6782648.00
SURE.L income_statement (annual, 2024-03-31) — Basic Average Shares: 6413341.00
SURE.L income_statement (annual, 2024-03-31) — Basic EPS: -0.36
SURE.L cash_flow (annual, 2024-03-31) — Beginning Cash Position: 36697.00
SURE.L balance_sheet (annual, 2024-03-31) — Capital Stock: 70514.00
SURE.L balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 65209.00
SURE.L balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Federal Funds Sold: 65209.00
SURE.L cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 0.00
SURE.L cash_flow (annual, 2024-03-31) — Change In Payable: 18569.00
SURE.L cash_flow (annual, 2024-03-31) — Change In Receivables: -6287.00
SURE.L cash_flow (annual, 2024-03-31) — Change In Working Capital: 12282.00
SURE.L cash_flow (annual, 2024-03-31) — Changes In Cash: 28512.00
SURE.L balance_sheet (annual, 2024-03-31) — Common Stock: 70514.00
SURE.L balance_sheet (annual, 2024-03-31) — Common Stock Equity: 5819730.00
SURE.L cash_flow (annual, 2024-03-31) — Common Stock Issuance: 400000.00
SURE.L income_statement (annual, 2024-03-31) — Diluted Average Shares: 6413341.00
SURE.L income_statement (annual, 2024-03-31) — Diluted EPS: -0.36
SURE.L income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: -2526478.00
SURE.L cash_flow (annual, 2024-03-31) — End Cash Position: 65209.00
SURE.L balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 6236446.00
SURE.L cash_flow (annual, 2024-03-31) — Financing Cash Flow: 583001.00
SURE.L cash_flow (annual, 2024-03-31) — Free Cash Flow: -356106.00
SURE.L cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: 2006368.00
SURE.L income_statement (annual, 2024-03-31) — Gain On Sale Of Security: -271039.00
SURE.L income_statement (annual, 2024-03-31) — General And Administrative Expense: 255203.00
SURE.L income_statement (annual, 2024-03-31) — Interest Expense: 22448.00
SURE.L income_statement (annual, 2024-03-31) — Interest Income: 0.00
SURE.L balance_sheet (annual, 2024-03-31) — Invested Capital: 6219730.00
SURE.L cash_flow (annual, 2024-03-31) — Investing Cash Flow: -198383.00
SURE.L balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 6236446.00
SURE.L balance_sheet (annual, 2024-03-31) — Investments And Advances: 6236446.00
SURE.L cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 400000.00
SURE.L cash_flow (annual, 2024-03-31) — Issuance Of Debt: 255000.00
SURE.L balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 400000.00
SURE.L cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 255000.00
SURE.L cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -55000.00
SURE.L cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 400000.00
SURE.L balance_sheet (annual, 2024-03-31) — Net Debt: 334791.00
SURE.L cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: 151722.00
SURE.L income_statement (annual, 2024-03-31) — Net Income: -2526478.00
SURE.L income_statement (annual, 2024-03-31) — Net Income Common Stockholders: -2526478.00
SURE.L income_statement (annual, 2024-03-31) — Net Income Continuous Operations: -2526478.00
SURE.L income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: -2526478.00
SURE.L income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: -2526478.00
SURE.L cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: -2526478.00
SURE.L income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: -2526478.00
SURE.L income_statement (annual, 2024-03-31) — Net Interest Income: -22448.00
SURE.L cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -198383.00
SURE.L cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 200000.00
SURE.L cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 200000.00
SURE.L cash_flow (annual, 2024-03-31) — Net Other Financing Charges: 0.00
SURE.L balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 5819730.00
SURE.L income_statement (annual, 2024-03-31) — Normalized Income: -2526478.00
SURE.L cash_flow (annual, 2024-03-31) — Operating Cash Flow: -356106.00
SURE.L income_statement (annual, 2024-03-31) — Operating Revenue: -2230538.00
SURE.L balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 7051600.00
SURE.L income_statement (annual, 2024-03-31) — Other Operating Expenses: 40737.00
SURE.L balance_sheet (annual, 2024-03-31) — Other Payable: 29238.00
SURE.L balance_sheet (annual, 2024-03-31) — Payables: 29238.00
SURE.L balance_sheet (annual, 2024-03-31) — Prepaid Assets: 8527.00
SURE.L income_statement (annual, 2024-03-31) — Pretax Income: -2526478.00
SURE.L cash_flow (annual, 2024-03-31) — Purchase Of Investment: -662460.00
SURE.L balance_sheet (annual, 2024-03-31) — Receivables: 0.00
SURE.L cash_flow (annual, 2024-03-31) — Repayment Of Debt: -55000.00
SURE.L cash_flow (annual, 2024-03-31) — Sale Of Investment: 464077.00
SURE.L income_statement (annual, 2024-03-31) — Selling General And Administration: 255203.00
SURE.L balance_sheet (annual, 2024-03-31) — Share Issued: 7051600.00
SURE.L balance_sheet (annual, 2024-03-31) — Stockholders Equity: 5819730.00
SURE.L balance_sheet (annual, 2024-03-31) — Tangible Book Value: 5819730.00
SURE.L income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
SURE.L income_statement (annual, 2024-03-31) — Tax Provision: 0.00
SURE.L income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.00
SURE.L balance_sheet (annual, 2024-03-31) — Total Assets: 6310182.00
SURE.L balance_sheet (annual, 2024-03-31) — Total Capitalization: 6219730.00
SURE.L balance_sheet (annual, 2024-03-31) — Total Debt: 400000.00
SURE.L balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 5819730.00
SURE.L balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 490452.00
SURE.L balance_sheet (quarterly, 2024-09-30) — Additional Paid In Capital: 7263731.00
SURE.L balance_sheet (quarterly, 2024-09-30) — Capital Stock: 76431.00
SURE.L balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 13265.00
SURE.L balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Federal Funds Sold: 13265.00
SURE.L balance_sheet (quarterly, 2024-09-30) — Common Stock: 76431.00
SURE.L balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 10614533.00
SURE.L balance_sheet (quarterly, 2024-09-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 11128216.00
SURE.L balance_sheet (quarterly, 2024-09-30) — Invested Capital: 11054533.00
SURE.L balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 11128216.00
SURE.L balance_sheet (quarterly, 2024-09-30) — Investments And Advances: 11128216.00
SURE.L balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 440000.00
SURE.L balance_sheet (quarterly, 2024-09-30) — Net Debt: 426735.00
SURE.L balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 10614533.00
SURE.L balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 7643252.00
SURE.L balance_sheet (quarterly, 2024-09-30) — Other Payable: 89826.00
SURE.L balance_sheet (quarterly, 2024-09-30) — Payables: 89826.00
SURE.L balance_sheet (quarterly, 2024-09-30) — Receivables: 2878.00
SURE.L balance_sheet (quarterly, 2024-09-30) — Share Issued: 7643252.00
SURE.L balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 10614533.00
SURE.L balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 10614533.00
SURE.L balance_sheet (quarterly, 2024-09-30) — Total Assets: 11144359.00
SURE.L balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 11054533.00
SURE.L balance_sheet (quarterly, 2024-09-30) — Total Debt: 440000.00
SURE.L balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 10614533.00
SURE.L balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 529826.00
SURE.L income_statement (annual, 2025-03-31) — +Operating Expense: 319301.00
SURE.L income_statement (annual, 2025-03-31) — +Total Revenue: 1042987.22
SURE.L balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 7498183.00
SURE.L balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 7498183.00
SURE.L income_statement (annual, 2025-03-31) — Basic Average Shares: 7540033.00
SURE.L income_statement (annual, 2025-03-31) — Basic EPS: 0.99
SURE.L cash_flow (annual, 2025-03-31) — Beginning Cash Position: 65209.00
SURE.L balance_sheet (annual, 2025-03-31) — Capital Stock: 79479.00